Cervical Cancer Diagnostics Market Segment Forecast 2015-2021

Published By:Zion Market Research

Cervical Cancer Diagnostics market - Global Industry Perspective,
Comprehensive Analysis and Forecast 2015-2021

Contact Us:
4283, Express Lane, Suite 634-143,
Sarasota, Florida 34249, United States
Tel: +1-386-310-3803 GMT
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

sales@zionmarketresearch.com

Cervical Cancer Diagnostics market

Cancer is a group of diseases involving abnormal growth of cells with the potential to spread
to other parts of the body. There are various types of cancers affecting different parts of
body. Cancer which develops in cervix is called cervical cancer. Two major types of cervical
cancers diagnosed in women include adenocarcinoma and squamous cell carcinoma. Almost
all types of cervical cancer are caused by human papiloma virus (HPV). Cervical cancer is
the third most common cancer among women and the second most frequent cause of
cancer-related death, accounting for almost 3,00,000 deaths annually. Diagnosis of cervical
cancer is done by Pap Smear Tests, Colposcopy, HPV Testing, Endocervical Curettage
(ECC). Cervical cancer is a sexually transmitted disease that can be prevented by early
detection and vaccination.
Request Sample at https://www.zionmarketresearch.com/sample/cervicalcancer-diagnostics-market

Cervical Cancer Diagnostics market
Cervical cancer diagnostics market is driven majorly by increasing percentage of HPV
infected people across globe. HPV is an extremely common virus. According to the Centers
for Disease Control and Prevention (CDC), six million people in the United States acquire
HPV each year. At least 20 million already have it, and more than half of all sexually-active
adults are expected to be infected during their lifetime. Furthermore, rising awareness,
literacy rate, government initiatives, government funding and various screening methods
are expected to increase the growth of the market over the years. Moreover, many...